Skip to content

Intensive Lifestyle Interventions to Overweight and Obese Patients in Primary Care

The Effect of Intensive Lifestyle Intervention Applied to Overweight and Obese Patients in Primary Care During the Pandemic Period: a Randomised Controlled Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06321809
Enrollment
165
Registered
2024-03-20
Start date
2022-01-25
Completion date
2022-12-01
Last updated
2025-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Life Style, Lifestyle, Sedentary

Keywords

primary care, obesity, lifestyle changes

Brief summary

The goal of this clinical trial is to compare in the effect of different lifestyle interventions in overweight and obese participants. The main questions it aims to answer are: * effect on anthropometric measurements * effect on lipid profile * effect on weight-related quality of life * observe the differences between interventions The study participants were stratified into three groups: intervention, control-1, and control-2. * Intervention group: They were given a calorie-restricted diet and exercise plan by a dietician or physiotherapist at their first visit, and were followed up by telephone calls at weeks 2, 4, 6, 8 and 10 over 12 weeks. * Control-1 group: During the initial medical interview, the participants were given a calorie-restricted diet programme by a dietician and an exercise programme by a physiotherapist; they were followed up over 12 weeks with telephone calls at week 4. * Control-2 group: The participants were not provided with any programme, and the importance of weight loss was emphasised by the family physicians. Dietary and physical activity advice was given according to the recommendations in the Turkish Endocrine and Metabolism Association 2019 Obesity Diagnosis and Treatment Guide, and was followed up with phone calls at weeks 2, 4, 6, 8 and 10 over a 12-weeks.

Detailed description

With this study, it is aimed to evaluate the effect of intensive lifestyle intervention to be applied to patients and follow-ups made by telephone calls in order to protect overweight and obese patients who apply to primary health care services from obesity and complications of obesity in the pandemic process in which the number of applications to secondary and tertiary care decreased due to pandemic conditions and the number of applications to primary care increased, in addition to this, the susceptibility to obesity increased due to changing lifestyle behaviours with the effect of the pandemic; The aim of this study is to evaluate the effect of intensive lifestyle intervention and telephone follow-ups on body mass index, body composition, lipid profile, obesity-related quality of life and to evaluate different forms of intervention organised as intensive lifestyle intervention and increasing the frequency of follow-up.

Interventions

INTENSIVE LIFESTYLE INTERVENTIONS

Sponsors

Hacettepe University
CollaboratorOTHER
Duygu Ayhan Baser
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years

Inclusion criteria

Age 18-40 BMI ≥ 25 kg/m 2 Agreeing to participate in the study Not having a diagnosed chronic disease To be able to ambulate To be cooperative

Exclusion criteria

* Receiving medical treatment * Secondary obesity (hypothyroidism, Cushing's disease, etc.) * Chronic disease (cardiovascular diseases, pulmonary diseases, presence of diabetes mellitus, liver diseases, renal diseases) * Having hyperlipidaemia under treatment * Cancer * Pregnancy or breastfeeding * Psychiatric disorder * Orthopaedic or neurological disease that may prevent walking * Are currently taking weight loss medication or enrolled in another weight loss program * Having previously undergone obesity surgery or having surgery planned during the study period

Design outcomes

Primary

MeasureTime frameDescription
Primary Outcome3 monthsTurkish version of the Impact of Weight on Quality of Life-Lite Version (IWQOL) scale was used. The scale has a minimum score of 0 and a maximum of 100. The scoring system is valid for both the scale subgroups and the scale total score. Based on the scale scoring, quality-of-life decreases as the score decreases.

Secondary

MeasureTime frameDescription
Secondary3 monthsComparing the anthropometric measurements of the three groups at baseline and week 12.
BMI (kg/m2)3 monthsComparing the BMI of the three groups at baseline and week 12.
Waist Circumference (cm)3 monthsComparing the Waist Circumference measurements of the three groups at baseline and week 12.
Lipid Profile3 monthsLipid profile of the three groups at baseline and week 12.

Countries

Turkey (Türkiye)

Participant flow

Recruitment details

The study's participants comprised of individuals with overweight and obese who made applications between the dates of 25th January 2022 and 1st October 2022 to the Department of Family Medicine.

Pre-assignment details

Sixteen participants were excluded from the study. Six participants were excluded due to having a BMI of less than 25 kg/m2. Two participants were excluded due to pregnancy or breastfeeding, and five participants were excluded due to having a chronic disease. Three participants were excluded due to their age, being either under 18 years old or over 40 years old.

Participants by arm

ArmCount
Intervention Group
They were given a calorie-restricted diet and exercise plan by a dietician or physiotherapist at their first visit, and were followed up by telephone calls at weeks 2, 4, 6, 8 and 10 over 12 weeks. intensive lifestyle: INTENSIVE LIFESTYLE INTERVENTIONS
51
Control-1 Group
During the initial medical interview, the participants were given a calorie-restricted diet programme by a dietician and an exercise programme by a physiotherapist; they were followed up over 12 weeks with telephone calls at week 4. intensive lifestyle: INTENSIVE LIFESTYLE INTERVENTIONS
51
Control-2 Group
The participants were not provided with any programme, and the importance of weight loss was emphasised by the family physicians. Dietary and physical activity advice was given according to the recommendations in the Turkish Endocrine and Metabolism Association 2019 Obesity Diagnosis and Treatment Guide, and was followed up with phone calls at weeks 2, 4, 6, 8 and 10 over a 12-weeks.
51
Total153

Baseline characteristics

CharacteristicIntervention GroupControl-1 GroupControl-2 GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
51 Participants51 Participants51 Participants153 Participants
Body Mass Index (kg/m2)
Obese (BMI greater than or equal to 30)
38 Participants28 Participants24 Participants90 Participants
Body Mass Index (kg/m2)
Overweight (BMI greater than or equal to 25)
13 Participants23 Participants27 Participants63 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
38 Participants34 Participants35 Participants107 Participants
Sex: Female, Male
Male
13 Participants17 Participants16 Participants46 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 00 / 0
other
Total, other adverse events
0 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 0

Outcome results

Primary

Primary Outcome

Turkish version of the Impact of Weight on Quality of Life-Lite Version (IWQOL) scale was used. The scale has a minimum score of 0 and a maximum of 100. The scoring system is valid for both the scale subgroups and the scale total score. Based on the scale scoring, quality-of-life decreases as the score decreases.

Time frame: 3 months

Population: All participants were analysed.

ArmMeasureGroupValue (MEDIAN)
Intervention GroupPrimary OutcomeSelf-esteem (baseline)50 score on a scale
Intervention GroupPrimary OutcomeSexual life (3 months)87.50 score on a scale
Intervention GroupPrimary OutcomeTotal Score (baseline)63.79 score on a scale
Intervention GroupPrimary OutcomeWork (3 months)87.50 score on a scale
Intervention GroupPrimary OutcomeSelf-esteem (3 months)75 score on a scale
Intervention GroupPrimary OutcomePhysical function (3 months)79.54 score on a scale
Intervention GroupPrimary OutcomeTotal Score (3 months)81.90 score on a scale
Intervention GroupPrimary OutcomePhysical function (baseline)68.18 score on a scale
Intervention GroupPrimary OutcomePublic distress (baseline)90 score on a scale
Intervention GroupPrimary OutcomeSexual life (baseline)75 score on a scale
Intervention GroupPrimary OutcomePublic distress (3 months)90 score on a scale
Intervention GroupPrimary OutcomeWork (baseline)75 score on a scale
Control-1 GroupPrimary OutcomePhysical function (3 months)77.27 score on a scale
Control-1 GroupPrimary OutcomeTotal Score (3 months)82.76 score on a scale
Control-1 GroupPrimary OutcomeSexual life (baseline)87.50 score on a scale
Control-1 GroupPrimary OutcomePublic distress (baseline)85 score on a scale
Control-1 GroupPrimary OutcomeWork (baseline)87.50 score on a scale
Control-1 GroupPrimary OutcomeTotal Score (baseline)73.28 score on a scale
Control-1 GroupPrimary OutcomeWork (3 months)87.50 score on a scale
Control-1 GroupPrimary OutcomeSelf-esteem (3 months)82.14 score on a scale
Control-1 GroupPrimary OutcomeSexual life (3 months)93.75 score on a scale
Control-1 GroupPrimary OutcomePublic distress (3 months)95 score on a scale
Control-1 GroupPrimary OutcomePhysical function (baseline)68.18 score on a scale
Control-1 GroupPrimary OutcomeSelf-esteem (baseline)57.14 score on a scale
Control-2 GroupPrimary OutcomeTotal Score (3 months)81.03 score on a scale
Control-2 GroupPrimary OutcomeSexual life (3 months)93.75 score on a scale
Control-2 GroupPrimary OutcomePublic distress (baseline)85 score on a scale
Control-2 GroupPrimary OutcomeWork (3 months)87.50 score on a scale
Control-2 GroupPrimary OutcomePublic distress (3 months)90 score on a scale
Control-2 GroupPrimary OutcomeSexual life (baseline)81.25 score on a scale
Control-2 GroupPrimary OutcomeSelf-esteem (baseline)50 score on a scale
Control-2 GroupPrimary OutcomePhysical function (3 months)84.09 score on a scale
Control-2 GroupPrimary OutcomeTotal Score (baseline)69.83 score on a scale
Control-2 GroupPrimary OutcomePhysical function (baseline)70.45 score on a scale
Control-2 GroupPrimary OutcomeSelf-esteem (3 months)60.71 score on a scale
Control-2 GroupPrimary OutcomeWork (baseline)87.50 score on a scale
Comparison: total scale score comparisonp-value: 0.24Wilcoxon (Mann-Whitney)
Comparison: total scale score comparisonp-value: 0.001Wilcoxon (Mann-Whitney)
Comparison: total scale score comparisonp-value: 0.03Wilcoxon (Mann-Whitney)
Comparison: total scale score comparisonp-value: 0.003Kruskal-Wallis
Secondary

BMI (kg/m2)

Comparing the BMI of the three groups at baseline and week 12.

Time frame: 3 months

Population: All participants were analysed.

ArmMeasureGroupValue (MEDIAN)
Intervention GroupBMI (kg/m2)BMI (kg/m2) (Baseline)31.50 kg/m2
Intervention GroupBMI (kg/m2)BMI (kg/m2) (3 months)30.60 kg/m2
Control-1 GroupBMI (kg/m2)BMI (kg/m2) (Baseline)30.50 kg/m2
Control-1 GroupBMI (kg/m2)BMI (kg/m2) (3 months)29.50 kg/m2
Control-2 GroupBMI (kg/m2)BMI (kg/m2) (Baseline)29.70 kg/m2
Control-2 GroupBMI (kg/m2)BMI (kg/m2) (3 months)29.20 kg/m2
Comparison: BMI Comparisonp-value: 0.13Kruskal-Wallis
Secondary

Lipid Profile

Lipid profile of the three groups at baseline and week 12.

Time frame: 3 months

Population: All participants were analysed.

ArmMeasureGroupValue (MEDIAN)
Intervention GroupLipid ProfileTriglyceride (Baseline)105 mg/dL
Intervention GroupLipid ProfileTotal cholesterol (Baseline)188 mg/dL
Intervention GroupLipid ProfileLDL cholesterol (Baseline)121 mg/dL
Intervention GroupLipid ProfileHDL cholesterol (Baseline)45 mg/dL
Intervention GroupLipid ProfileTriglyceride (3 months)100 mg/dL
Intervention GroupLipid ProfileTotal cholesterol (3 months)189 mg/dL
Intervention GroupLipid ProfileLDL cholesterol (3 months)128 mg/dL
Intervention GroupLipid ProfileHDL cholesterol (3 months)50 mg/dL
Control-1 GroupLipid ProfileLDL cholesterol (Baseline)120 mg/dL
Control-1 GroupLipid ProfileLDL cholesterol (3 months)125 mg/dL
Control-1 GroupLipid ProfileHDL cholesterol (Baseline)50 mg/dL
Control-1 GroupLipid ProfileTriglyceride (3 months)98 mg/dL
Control-1 GroupLipid ProfileTotal cholesterol (3 months)189 mg/dL
Control-1 GroupLipid ProfileTriglyceride (Baseline)110 mg/dL
Control-1 GroupLipid ProfileTotal cholesterol (Baseline)193 mg/dL
Control-1 GroupLipid ProfileHDL cholesterol (3 months)48 mg/dL
Control-2 GroupLipid ProfileLDL cholesterol (Baseline)126 mg/dL
Control-2 GroupLipid ProfileTotal cholesterol (Baseline)181 mg/dL
Control-2 GroupLipid ProfileTriglyceride (Baseline)94 mg/dL
Control-2 GroupLipid ProfileHDL cholesterol (Baseline)46 mg/dL
Control-2 GroupLipid ProfileLDL cholesterol (3 months)129 mg/dL
Control-2 GroupLipid ProfileTotal cholesterol (3 months)173 mg/dL
Control-2 GroupLipid ProfileTriglyceride (3 months)96 mg/dL
Control-2 GroupLipid ProfileHDL cholesterol (3 months)48 mg/dL
Comparison: LDL Cholesterol Comparisonp-value: 0.89Kruskal-Wallis
Secondary

Secondary

Comparing the anthropometric measurements of the three groups at baseline and week 12.

Time frame: 3 months

Population: All participants were analysed.

ArmMeasureGroupValue (MEDIAN)
Intervention GroupSecondaryWeight (kg) (Baseline)89.50 kg
Intervention GroupSecondaryFat mass (kg) (Baseline)33.50 kg
Intervention GroupSecondaryFat free mass (kg) (Baseline)52.80 kg
Intervention GroupSecondaryWeight (kg) (3 months)88 kg
Intervention GroupSecondaryFat mass (kg) (3 months)31.10 kg
Intervention GroupSecondaryFat free mass (kg)(3 months)51.90 kg
Control-1 GroupSecondaryFat free mass (kg)(3 months)48.50 kg
Control-1 GroupSecondaryWeight (kg) (Baseline)84.50 kg
Control-1 GroupSecondaryWeight (kg) (3 months)79.90 kg
Control-1 GroupSecondaryFat mass (kg) (3 months)28.80 kg
Control-1 GroupSecondaryFat mass (kg) (Baseline)28.70 kg
Control-1 GroupSecondaryFat free mass (kg) (Baseline)50 kg
Control-2 GroupSecondaryFat mass (kg) (Baseline)26.80 kg
Control-2 GroupSecondaryFat free mass (kg) (Baseline)53.40 kg
Control-2 GroupSecondaryFat free mass (kg)(3 months)53.80 kg
Control-2 GroupSecondaryWeight (kg) (3 months)84 kg
Control-2 GroupSecondaryWeight (kg) (Baseline)85.10 kg
Control-2 GroupSecondaryFat mass (kg) (3 months)25.20 kg
Comparison: Weight comparisonp-value: 0.08Kruskal-Wallis
Secondary

Waist Circumference (cm)

Comparing the Waist Circumference measurements of the three groups at baseline and week 12.

Time frame: 3 months

Population: All participants were analysed.

ArmMeasureGroupValue (MEDIAN)
Intervention GroupWaist Circumference (cm)Waist circumference (cm) (Baseline)106 cm
Intervention GroupWaist Circumference (cm)Waist circumference (cm) (3 months)102 cm
Control-1 GroupWaist Circumference (cm)Waist circumference (cm) (Baseline)101.50 cm
Control-1 GroupWaist Circumference (cm)Waist circumference (cm) (3 months)100 cm
Control-2 GroupWaist Circumference (cm)Waist circumference (cm) (Baseline)101 cm
Control-2 GroupWaist Circumference (cm)Waist circumference (cm) (3 months)100 cm
Comparison: Waist Circumference Comparisonp-value: 0.63Kruskal-Wallis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026